跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dalamycin
Approved
STANDARD
Dalamycin
North China Pharmaceutical Co., Ltd. (New Preparation Branch Factory)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
71ff5dd745d6e90c
Company
North China Pharmaceutical Co., Ltd. (New Preparation Branch Factory)
Type
Standard
Approval Details
Approval Id
71ff5dd745d6e90c
Drug Approval Philippines Name
Dalamycin
Product Name
Dalamycin
Registration Number
DRP-13816
Brand Name
Dalamycin
Generic Name
Clindamycin (as phosphate)
Dosage Form
Solution for Injection (IM/IV)
Dosage Strength
150 mg/mL (600 mg/ 4 mL)
Manufacturer
North China Pharmaceutical Co., Ltd. (New Preparation Branch Factory)
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
29 April 2023
Expiry Date
27 July 2026
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
71ff5dd745d6e90c
Type
Standard
Back to Philippines FDA Approvals
Dalamycin - Philippines FDA Drug Approval Details